ENTITY: - **Ginkgo Bioworks**
DATE: 13-03-2026

**Forensic Audit Memo – Ginkgo Bioworks (Synthetic Biology)**

1. **Objective:** Assess financial and operational integrity of Ginkgo Bioworks’ synthetic biology contracts, focusing on revenue recognition, R&D cost allocation, and IP licensing compliance.
2. **Scope:** Review 2023–2024 financial statements, third-party collaborations, and biosecurity protocols for anomalies or misclassifications.
3. **Key Risks:** Potential overstatement of contract revenues, misaligned R&D expenses, and inadequate IP safeguards in joint ventures.
4. **Next Steps:** Conduct on-site inspections of lab facilities and digital forensics on transactional data to validate findings.

**Prepared by:** [Your Name/Team]
**Date:** [Insert Date]

[NOTARIZED BY 2A AGENCY]